China Resources Double-Crane Pharmaceutical Co.,Ltd.
600062Pharmaceuticals
CN¥15.17−2.32%As of Oct 29vs prior close
- Market cap
- $2.4B
- P/E (TTM)
- 10.3×
- P/E (FY1)
- 8.9×
- From 52W high
- −22.99%
- EPS (LTM)
- CN¥1.56
- Revenue (LTM)
- CN¥10.8B
- Net margin
- 14.55%
Nomior Score
40
Patient ValueBottom 28% of the scored universe
Growth39
Quality51
Value69
Momentum1
Resilience64
Growth
+4.55%revenue a year over 3 fiscal years
YE22 CN¥9.6BLTM CN¥10.8B
Connections
Revenue to profitYE25
15% of revenue became net profit.